Coronary bifurcations stenosis: definition, classification of lesions, classification of techniques, measurements

Size: px
Start display at page:

Download "Coronary bifurcations stenosis: definition, classification of lesions, classification of techniques, measurements"

Transcription

1 Coronary bifurcations stenosis: definition, classification of lesions, classification of techniques, measurements Y. Louvard, ICPS, Massy, Générale de Santé, France European Bifurcation Club 10th anniversary meeting Bordeaux, France, October 17-18th 2014

2

3

4 Presented by Bernard Chevalier in the 1st EBC meeting, september 16th 2005

5 Definition of a coronary bifurcation stenosis

6

7

8 Fonctional hierarchy of coronary circulation: direct evidence of structure-fonction relation Kassab, Am J Physiol Heart Circ Physiol 289: H , 2005

9

10

11 Scaling laws of vascular trees: of form and function Kassab, Am J Physiol Heart Circ Physiol 290: H894-H903, 2006

12

13 Scaling of myocardial mass to flow and morphometry of coronary arteries Choy, Kassab, J Appl Physiol 104: , 2008

14

15 How to define a bifurcation lesion? A coronary artery narrowing occuring adjacent to, and/or involving, the origin of a significant side branch A significant SB is a branch that you don't want to loose in the global context of a particular patient Y. Louvard Catheter Cardiovasc Interv Feb 1;71:175-83

16 Bifurcation or not?

17 Classification of bifurcation lesions

18 Classifications of bifurcation lesions Duke Sanborn Safian Icps-Lefevre Syntax classification Chen - Gao

19

20 A New Proposed Simplified Classification of Coronary Artery Bifurcation Lesions and Bifurcation Interventional Techniques Movahed, J Invas Cardiol 2006;18:

21 A New Proposed Simplified Classification of Coronary Artery Bifurcation Lesions and Bifurcation Interventional Techniques BL1nT-CA BL1sT-LM BL2T-LM-CA? Movahed, J Invas Cardiol 2006;18:

22 Major Limitations of Randomized Clinical Trials Involving Coronary Artery Bifurcation Interventions: Time for Redesigning Clinical Trials by Involving Only True Bifurcation Lesions and Using Appropriate Bifurcation Classification Suggested algorithmic approach for randomized clinical trials involving coronary bifurcation intervention Movahed. Journal of Interventional Cardiology 2011

23 MB (Proximal) 0, 1 Medina Classification MB (Distal) 0, 1 SB 0, 1 1,1,1 1,1,0 1,0,1 0,1,1 1,0,0 0,1,0 0,0,1 Medina et al. Rev. Esp. Cardiol 2006; 59(2): 183-4

24 Name the bifurcation Why?: - for Medina classification (which branch is the SB?) - for stenting technique definition - for intention to treat analysis A B C D Cx1,Mg1,Cx2 1,0,0 LAD1,LAD1,Dg1 1,1,1 RCA2,RCA2,Mgr 0,1,1 LM,LAD1,Ram,Cx1 1,1,0,1 E F G H LAD1,LAD1,Dg1,Dg2 0,1,1,1 Mg2,Br2,Br1 0,1,0 RCA3,PDA,PLA 1,0,0 LAD1,Dg1,LAD2 1,1,1 Louvard Y. CCI. 2008, 71:

25 What is our Medina classification? Simple Easy to remember Research classification Incomplete (angle, SB lesion length, Ca++ ) Can be completed by quantification Visual / base on quantification IVUS Medina, OCT Medina, FFR Medina

26 Todaro, Burzotta, Rev Esp Cardiol. 2009;62(6):606-14

27 Evaluation of a Strategy for Treating Bifurcated Lesions by Single or Double Stenting Based on the Medina Classification Todaro, Burzotta.Rev Esp Cardiol. 2009;62(6):606-14

28 Evaluation of a Strategy for Treating Bifurcated Lesions by Single or Double Stenting Based on the Medina Classification Todaro, Burzotta, Rev Esp Cardiol. 2009;62(6):606-14

29 Quantification of a coronary bifurcation stenosis

30 D1 Murray s law 3* 3* 3* D 1 = D2 + D3 D3 Finet s formula D1= (D2+D3) X 0,678 D2 * 2.3 (Huo-Kassab) Adapted from G. Kassab

31 Traditional QCA for coronary bifurcation quantification: reference, MLD, %

32

33 Dedicated bifurcation QCA

34 Bifurcation

35 Quantitative Angiographic Methods for Bifurcation Lesions: A Consensus Statement from the EuropeanBifurcation Group Subsegment analysis demonstrating the various segments that should be analyzed and reported separately Lansky, CCVI 73: (2009)

36 Classification of bifurcation stenting techniques

37 Classification of Treatments A B C D + High Tech meeting 1997

38 Classification of Treatments A Technique B Technique C Technique D Technique or 2 1 or «Skirt» Technique Y. Louvard, Heart 2004; 90 :

39 Exhaustive? Simple? Schematic description of interventional bifurcation techniques: OST = one stent technique; SBT = stent with balloon technique; KST= kissing stent technique; TST = T stenting technique; CRT = crush stenting technique; CUT = culotte stenting technique Movahed. J Invasive Cardiol May;18(5):

40 M Main prox. first A Main Accross side first D Double first S Side branch first 1 st stent PM stenting MB stenting across SB DM stenting Provisional SKS SB ostial stenting After balloon Skirt MB stenting + SB balloon MB stenting + kissing SB SB crush minicrush 2 stents Skirt + DM Skirt + SB Elective T stenting Internal crush Culotte TAP V stenting SKS Syst. T Stenting Minicrush Crush 3 stents Extended V Trouser legs and seat

41 M Main prox. first A Main Accross side first D Distal first S Side branch first 1 st stent Inv. MB stenting across SB Inv. Provisional SKS DM ostial stenting After balloon MB to SB stenting + DM balloon MB to SB stenting + kissing DM minicrush DM crush 2 stents Inv. Inv. Elective Internal T stenting crush Inv. Culotte Inv. TAP Inv. Inv. Syst. Minicrush Crush Inv. T Stenting 3 stents

42 Two-stent strategies for bifurcation lesions: which vessel should be stented first, the main vessel or the side ranch? Adjusted incidences of cardiac death, MI and stent thrombosis using inverse probability weight (A) and standardized mortality/morbidity ratio weight (B) Shin, J Korean Med Sci 2011; 26:

43 e- CRF? MB stenting accross SB first MB stenting with protection MB stenting with SB balloon Proximal MB stenting first 1st stent 2nd stent 3rd stent Proximal MB stenting Wires 1st stent? Helqvist Elective T stenting Internal Crush Culotte «Buchbinder?» Skirt technique 2nd stent DK-Crush technique, Chen, Eur J Clin Invest 2008; 38 (6): SB stenting first Distal branches stenting first Balloons SB ostial stenting SB Crush stenting 1st stent 1st and 2nd stent 3rd stent V stenting V + proximal stenting 1st stent Systematic T stenting Minicrush Crush technique ½ SKS SKS 2nd stent Intention Inverted

44 Conclusions Better definition of bifurcation stenosis? Possible? Useful? Do we need another classification than the Medina s? No Classification of treatments: how to take into account the complexity of techniques? What is missing?

Coronary Bifurcation Treatment: Update from the European Bifurcation Club. Remo Albiero, MD Ist. Clinico S. Rocco Brescia (Italy)

Coronary Bifurcation Treatment: Update from the European Bifurcation Club. Remo Albiero, MD Ist. Clinico S. Rocco Brescia (Italy) Coronary Bifurcation Treatment: Update from the European Bifurcation Club Remo Albiero, MD Ist. Clinico S. Rocco Brescia (Italy) Disclosure Statement of Financial Interest Within the past 12 months, I

More information

Ostial LAD: Single stent approach is the best. Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI

Ostial LAD: Single stent approach is the best. Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI Ostial LAD: Single stent approach is the best Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI Chair, Interventional Cardiology Sanatorio San Lucas Instituto Alexander Fleming Buenos

More information

Clinical Research Intracoronary Stenting with Crushing in Coronary Artery Bifurcation Lesions: Initial Results and Medium-Term Follow Up

Clinical Research Intracoronary Stenting with Crushing in Coronary Artery Bifurcation Lesions: Initial Results and Medium-Term Follow Up Hellenic J Cardiol 45: 379-383, 2004 Clinical Research Intracoronary Stenting with Crushing in Coronary Artery Bifurcation Lesions: Initial Results and Medium-Term Follow Up PETROS S. DARDAS, DIMITRIS

More information

Early And Late Outcome For Single Versus Double Stenting For Bifurcational Coronary Artery Lesions

Early And Late Outcome For Single Versus Double Stenting For Bifurcational Coronary Artery Lesions ORIGINAL CONTRBUTION / CLINICAL INVESTIGATION Early And Late Outcome For Single Versus Double Stenting For Bifurcational Coronary Artery Lesions Aram J. Mirza Correspondence: Dr. Aram J.Mirza Interventional

More information

Editorial. Adult Cardiology - Meta-analysis

Editorial. Adult Cardiology - Meta-analysis Editorial Adult Cardiology - Meta-analysis Simple Versus Complex Bifurcation Stenting Strategies A Meta Analysis of Randomized Controlled Trials in the Drug Eluting Stent Era Ana Beatriz R. Medrano, MD

More information

Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10 years of the European Bifurcation Club meetings

Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10 years of the European Bifurcation Club meetings CLINICAL RESEARCH CORONARY INTERVENTIONS Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10 years of the European Bifurcation Club meetings Jens Flensted Lassen

More information

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient?

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient? Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient? --- NIRS-IVUS TVC Imaging Adds Additional Information for the Heart Team Dr. Luis Tami Memorial Regional Hospital

More information

CORONARY BIFURCATION DISEASE AND BIFURCATION STENTING: A PRACTICAL APPROACH

CORONARY BIFURCATION DISEASE AND BIFURCATION STENTING: A PRACTICAL APPROACH CORONARY BIFURCATION DISEASE AND BIFURCATION STENTING: A PRACTICAL APPROACH Riccardo Colantonio, 1 Enrico Romagnoli, 2 *Giuseppe Sangiorgi 2,3 1. Department of Cardiology, Cardiac Cath Lab, San Pietro

More information

Cilostazol versus Clopidogrel after Coronary Stenting

Cilostazol versus Clopidogrel after Coronary Stenting Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background

More information

Drug-Eluting Balloons. Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam

Drug-Eluting Balloons. Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam Drug-Eluting Balloons Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam Potential conflicts of interest Speaker s name: Klaus Bonaventura

More information

StentViz Enhanced Stent Visualization

StentViz Enhanced Stent Visualization GE Healthcare StentViz Enhanced Stent Visualization Dr. Morice, Dr. Lefèvre, Dr. Hovasse, Dr. Chevalier, Dr. Louvard Institut Cardiovasculaire Paris Sud, Massy, France Assessing the deployment of stents

More information

The Bioresorbable Vascular Stent Dr Albert Ko

The Bioresorbable Vascular Stent Dr Albert Ko The Bioresorbable Vascular Stent Dr Albert Ko Dr Albert Ko MB BS, FRACP, FCSANZ Interventional/General Cardiologist Ascot Cardiology Symposium 2013 Treatment Goals for Coronary Artery Disease Relieve of

More information

California Health and Safety Code, Section 1256.01

California Health and Safety Code, Section 1256.01 California Health and Safety Code, Section 1256.01 1256.01. (a) The Elective Percutaneous Coronary Intervention (PCI) Pilot Program is hereby established in the department. The purpose of the pilot program

More information

SAMPLE. Asia-Pacific Interventional Cardiology Procedures Outlook to 2020. Reference Code: GDMECR0061PDB. Publication Date: May 2014

SAMPLE. Asia-Pacific Interventional Cardiology Procedures Outlook to 2020. Reference Code: GDMECR0061PDB. Publication Date: May 2014 Asia-Pacific Interventional Cardiology Procedures Outlook to 2020 Reference Code: GDMECR0061PDB Publication Date: May 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2

More information

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Duration of Dual Antiplatelet Therapy After Coronary Stenting Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are

More information

CARDIAC RISKS OF NON CARDIAC SURGERY

CARDIAC RISKS OF NON CARDIAC SURGERY CARDIAC RISKS OF NON CARDIAC SURGERY N E W S T U D I E S & N E W G U I D E L I N E S W. B. C A L H O U N, M D, F A C C 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management

More information

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Total Cardiology, Calgary Acknowledgements and Disclosures Acknowledgements Jacques Genest

More information

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-elevation myocardial infarction 3 year follow-up of the randomised trial Peter Clemmensen, Henning Kelbæk,

More information

University of Ulsan College of Medicine, Asan Medical Center on behalf of the REAL-LATE and the ZEST-LATE trial

University of Ulsan College of Medicine, Asan Medical Center on behalf of the REAL-LATE and the ZEST-LATE trial Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation A Pooled Analysis of the REAL-LATE and the ZEST-LATE Trial Seung-Jung Park MD PhD Seung-Jung Park, MD, PhD, University of Ulsan

More information

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease PRECOMBAT Trial Seung-Whan Lee, MD, PhD On behalf

More information

The Minvasys Amazonia Pax & Nile Pax Polymer Free Paclitaxel Eluting Stent Program

The Minvasys Amazonia Pax & Nile Pax Polymer Free Paclitaxel Eluting Stent Program The Minvasys Amazonia Pax & Nile Pax Polymer Free Paclitaxel Eluting Stent Program Jean Fajadet, MD, FESC Clinique Pasteur - Toulouse - France Disclosure statement Nothing to disclose Dedicated Delivery

More information

Abstract Aims: To analyse the ultrasound anatomy of bifurcation lesions {1,1,0},{0,1,0} and {1,0,0} of the Medina CLINICAL RESEARCH

Abstract Aims: To analyse the ultrasound anatomy of bifurcation lesions {1,1,0},{0,1,0} and {1,0,0} of the Medina CLINICAL RESEARCH CLINICAL RESEARCH n Predictors of ostial side branch damage during provisional stenting of coronary bifurcation lesions not involving the side branch origin: an ultrasonographic study Javier Suárez de

More information

Majestic Trial 12 Month Results

Majestic Trial 12 Month Results Majestic Trial 12 Month Results S.Müller-Hülsbeck, MD, EBIR, FCIRSE, FICA ACADEMIC HOSPITALS Flensburg of Kiel University Ev.-Luth. Diakonissenanstalt zu Flensburg Knuthstraße 1, 24939 FLENSBURG Dept.

More information

Clinical Study Synopsis

Clinical Study Synopsis Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace

More information

INTERVENTION IN OSTIAL CORONARY LESIONS:

INTERVENTION IN OSTIAL CORONARY LESIONS: INTERVENTION IN OSTIAL CORONARY LESIONS: Antony (92), le 18 septembre 2013 JEAN MARC PERNES Hopital Privé Antony FRANCE Perfection of Precise Ostial Stent Placement Ostial lesions, including aorta ostial

More information

PIHRATE Trial. Polish-Italian-Hungarian Randomized ThrombEctomy Trial. Dariusz Dudek MD, PhD. On behalf PIHRATE investigators

PIHRATE Trial. Polish-Italian-Hungarian Randomized ThrombEctomy Trial. Dariusz Dudek MD, PhD. On behalf PIHRATE investigators Polish-Italian-Hungarian Randomized ThrombEctomy Trial PIHRATE Trial On behalf PIHRATE investigators Dariusz Dudek MD, PhD Institute of Cardiology, Krakow, Poland Impact of distal embolization Distal embolization

More information

A Post-market Study to Assess the STENTYS Self-exPanding COronary Stent In AcuTe myocardial InfarctiON in Real Life APPOSITION III

A Post-market Study to Assess the STENTYS Self-exPanding COronary Stent In AcuTe myocardial InfarctiON in Real Life APPOSITION III A Post-market Study to Assess the STENTYS Self-exPanding COronary Stent In AcuTe myocardial InfarctiON in Real Life APPOSITION III Gilles Montalescot, MD, PhD Pitié-Salpêtrière Hospital, Paris, France

More information

Experience of Direct Coronary Stenting at National Institute of Cardiovascular Diseases

Experience of Direct Coronary Stenting at National Institute of Cardiovascular Diseases Experience of Direct Coronary Stenting at National Institute of Cardiovascular Diseases T. Masood,T. Sagheer,D. Jan,N. Qamar,A.M.A. Faruqui ( National Institute of Cardiovascular Diseases (NICVD), Karachi.

More information

Ch. 138 CARDIAC CATHETERIZATION SERVICES 28 138.1 CHAPTER 138. CARDIAC CATHETERIZATION SERVICES GENERAL PROVISIONS

Ch. 138 CARDIAC CATHETERIZATION SERVICES 28 138.1 CHAPTER 138. CARDIAC CATHETERIZATION SERVICES GENERAL PROVISIONS Ch. 138 CARDIAC CATHETERIZATION SERVICES 28 138.1 CHAPTER 138. CARDIAC CATHETERIZATION SERVICES Sec. 138.1 Principle. 138.2. Definitions. GENERAL PROVISIONS PROGRAM, SERVICE, PERSONNEL AND AGREEMENT REQUIREMENTS

More information

European Heart Journal (1999) 20, 1014 1019 Article No. euhj.1998.1395, available online at http://www.idealibrary.com on

European Heart Journal (1999) 20, 1014 1019 Article No. euhj.1998.1395, available online at http://www.idealibrary.com on European Heart Journal (1999) 20, 1014 1019 Article No. euhj.1998.1395, available online at http://www.idealibrary.com on Working Group Report Indications for intracoronary stent placement: the European

More information

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs A Patient s Guide to Primary and Secondary Prevention of PATIENT EDUCATION GUIDE What Is Cardiovascular Disease? Cardiovascular disease (CVD) is a broad term that covers any disease of the heart and circulatory

More information

INTRODUCTION. Key Words:

INTRODUCTION. Key Words: Case Report Acta Cardiol Sin 2014;30:485 489 Successful Revascularization of Chronic Total Occlusion in Native Coronary Arteries through an Occluded Saphenous Bypass Vein Graft: A Retrograde Alternative

More information

The Cardiac Society of Australia and New Zealand

The Cardiac Society of Australia and New Zealand The Cardiac Society of Australia and New Zealand Guidelines on Support Facilities for Coronary Angiography and Percutaneous Coronary Intervention (PCI) including Guidelines on the Performance of Procedures

More information

Rotational Atherectomy for the Treatment of In-Stent Restenosis

Rotational Atherectomy for the Treatment of In-Stent Restenosis Home SVCC Area: English - Español - Português Rotational Atherectomy for the Treatment of In-Stent Restenosis Steven L. Goldberg, MD Cardiac Catheterization Laboratory, University of Washington Medical

More information

Mattias Törnerud, Capio St Görans sjukhus AB, Stockholm. Invasiv tryckmätning FFR

Mattias Törnerud, Capio St Görans sjukhus AB, Stockholm. Invasiv tryckmätning FFR Namn: Titel: Mattias Törnerud, Capio St Görans sjukhus AB, Stockholm Invasiv tryckmätning FFR Har mo/agit förläsararvoden från St Jude Medical. Intrakoronar tryckmätning, FFR i daglig praxis 1000 angio

More information

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty Round Table: Antithrombotic therapy beyond ACS Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty M. Matsagkas, MD, PhD, EBSQ-Vasc Associate Professor

More information

Three-dimensional coronary reconstruction from routine single-plane coronary angiograms: in vivo quantitative validation

Three-dimensional coronary reconstruction from routine single-plane coronary angiograms: in vivo quantitative validation International Journal of Cardiovascular Interventions. 2005; 7: 141 145 ORIGINAL ARTICLE Three-dimensional coronary reconstruction from routine single-plane coronary angiograms: in vivo quantitative validation

More information

MEDICAL POLICY No. 91580-R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE

MEDICAL POLICY No. 91580-R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE Effective Date: October 1, 2015 Review Dates: 10/11, 10/12, 10/13, 8/14, 8/15 Date Of Origin: October 12, 2011 Status: Current Summary of Changes Clarifications:

More information

FFR in bifurcation stenting: what have we learned?

FFR in bifurcation stenting: what have we learned? Clinical and technical aspects FFR in bifurcation stenting: what have we learned? Bon-Kwon Koo 1, MD, PhD; Bernard De Bruyne 2, MD, PhD 1. Seoul National University Hospital, Seoul, Korea; 2. Cardiovascular

More information

Clinical Training for Visage 7 Cardiac. Visage 7

Clinical Training for Visage 7 Cardiac. Visage 7 Clinical Training for Visage 7 Cardiac Visage 7 Overview Example Usage 3 Cardiac Workflow Examples 4 Remove Chest Wall 5 Edit Chest Wall Removal 6 Object Display Popup 7 Selecting Optimal Phase 8 Thick

More information

Flash, Rocking on others Added value in DCM and CRT. C. Parsai Polyclinique des Fleurs France

Flash, Rocking on others Added value in DCM and CRT. C. Parsai Polyclinique des Fleurs France Flash, Rocking on others Added value in DCM and CRT C. Parsai Polyclinique des Fleurs France Cleland JGF et al. (2007) Nat Clin Pract Cardiovasc Med 4: 90 101 Predicting CRT Response Device Related Patient

More information

The Pantera Lux Paclitaxel DEB Device Description and Clinical Studies. Christoph Hehrlein, University Clinic Freiburg i.br.

The Pantera Lux Paclitaxel DEB Device Description and Clinical Studies. Christoph Hehrlein, University Clinic Freiburg i.br. The Pantera Lux Paclitaxel DEB Device Description and Clinical Studies Christoph Hehrlein, University Clinic Freiburg i.br. Germany Disclosure Statement of Financial Interest Within the past 12 months,

More information

Yukon Choice DES + Translumina - The polymer-free DES solution. www.translumina.de. Coronary Stent System for Drug Application

Yukon Choice DES + Translumina - The polymer-free DES solution. www.translumina.de. Coronary Stent System for Drug Application Coronary Stent System for Drug Application Yukon Choice DES + new catheter polymer-free DES Translumina - The polymer-free DES solution www.translumina.de A First Class Stent The YUKON Choice DES+ is the

More information

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate

More information

The left internal mammary artery (LIMA) is the

The left internal mammary artery (LIMA) is the Case Report 925 Direct Stenting of a Transradial Left Internal Mammary Artery Graft Wei-Chin Hung, MD; Bih-Fang Guo, MD, PhD; Chiung-Jen Wu, MD; Chien-Jen Chen, MD; Chih-Yuan Fang, MD Taking the transfemoral

More information

Ischemia and Infarction

Ischemia and Infarction Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Badizadegan Ischemia and Infarction HST.035 Spring 2003 In the US: ~50% of deaths are due to

More information

Samir B. Pancholy, MD, FACC, FSCAI 570-840-9852

Samir B. Pancholy, MD, FACC, FSCAI 570-840-9852 Samir B. Pancholy, MD, FACC, FSCAI 570-840-9852 Medical School: B.J. Medical College, Ahmedabad, India 6-1981 to 5-1987. Residency: State University of New York at Stony Brook, Stony Brook, NY, Internal

More information

For the NXT Investigators

For the NXT Investigators Diagnostic performance of non-invasive fractional flow reserve derived from coronary CT angiography in suspected coronary artery disease: The NXT trial Bjarne L. Nørgaard, Jonathon Leipsic, Sara Gaur,

More information

REPORTING STENT PLACEMENT FOR NONOCCLUSIVE VASCULAR DISEASE IN LOWER EXTREMITIES

REPORTING STENT PLACEMENT FOR NONOCCLUSIVE VASCULAR DISEASE IN LOWER EXTREMITIES REPORTING STENT PLACEMENT FOR NONOCCLUSIVE VASCULAR DISEASE IN LOWER EXTREMITIES Effective January 1, 2015, there was a change in CPT that affects reporting specific endovascular services provided in the

More information

Kawasaki Disease Complicated by Coronary Artery Aneurysms: Mortality and 40-year Outcomes

Kawasaki Disease Complicated by Coronary Artery Aneurysms: Mortality and 40-year Outcomes Kawasaki Disease Complicated by Coronary Artery Aneurysms: Mortality and 40-year Outcomes C. Manlhiot, A. Crean, N. Fernandopulle, B. Lew, N. Chahal, B.W. McCrindle Division of Cardiology, Department of

More information

Advances in Stent Technology

Advances in Stent Technology Nurse/Technologist Symposium Advances in Stent Technology Antonietta Tolentino, CCRN, MSN, ANP-C Adult Nurse Practitioner, Cardiac Catheterization Laboratory The Zena and Michael A. Weiner Cardiovascular

More information

Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter

Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter Endoskopische Venenentnahme (EVH) - Einführung 1979 Tevaearai und Kollegen haben

More information

DATE: 29 August 2012 CONTEXT AND POLICY ISSUES

DATE: 29 August 2012 CONTEXT AND POLICY ISSUES TITLE: Dual Antiplatelet Therapy and Enoxaparin or Unfractionated Heparin for patients with ST-elevation Myocardial Infarction: A Review of the Clinical Evidence DATE: 29 August 2012 CONTEXT AND POLICY

More information

HA Territory-wide PCI Audit 2003-05

HA Territory-wide PCI Audit 2003-05 HA Territory-wide PCI Audit 23-5 5 PCI Audit Working Group Central Committee (Cardiac Services) HA Convention 26 Percutaneous Coronary Intervention Background HA AP target 2/3, coordinated by PCI Working

More information

GUIDELINES ON MEDICAL DEVICES EVALUATION OF CLINICAL DATA - A GUIDE FOR MANUFACTURERS AND NOTIFIED BODIES -

GUIDELINES ON MEDICAL DEVICES EVALUATION OF CLINICAL DATA - A GUIDE FOR MANUFACTURERS AND NOTIFIED BODIES - EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Cosmetics and Medical Devices MEDDEV 2.7.1 Appendix 1 December 2008 GUIDELINES ON MEDICAL DEVICES EVALUATION OF CLINICAL DATA

More information

Understanding and Preparing for a CAtHeteRIZAtIon PRoCeDURe

Understanding and Preparing for a CAtHeteRIZAtIon PRoCeDURe Understanding and Preparing for a CAtHeteRIZAtIon PRoCeDURe The Massachusetts General Hospital Heart Center and Vascular Center welcome you to the Knight Center for Interventional Cardiovascular Therapy.

More information

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize

More information

2015 European Cardiovascular Image Management Technology Leadership Award

2015 European Cardiovascular Image Management Technology Leadership Award 2015 European Cardiovascular Image Management Technology Leadership Award 2015 Contents Background and Company Performance... 3 Industry Challenges... 3 Technology Leverage and Business Impact... 4 Conclusion...

More information

Efficient Evaluation of Chest Pain

Efficient Evaluation of Chest Pain Efficient Evaluation of Chest Pain Vikranth Gongidi, DO FACC FACOI Indian River Medical Center Vero Beach, FL No Disclosures Outline Background Chest pain pathway Indications for stress test Stress test

More information

MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION. POLICY NUMBER: 8.01.14 CATEGORY: Therapy/ Rehabilitation

MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION. POLICY NUMBER: 8.01.14 CATEGORY: Therapy/ Rehabilitation MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy

More information

Echocardiography Guided Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure and Narrow QRS Complex

Echocardiography Guided Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure and Narrow QRS Complex Echocardiography Guided Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure and Narrow QRS Complex Johannes Holzmeister, M.D. University of Zurich, Zurich, Switzerland on behalf

More information

The Elective Percutaneous Coronary Intervention (PCI) Pilot Program. Report to the Legislature

The Elective Percutaneous Coronary Intervention (PCI) Pilot Program. Report to the Legislature State of California Health and Human Services Agency California Department of Public Health RON CHAPMAN, MD, MPH Director & State Health Officer EDMUND G. BROWN, JR. Governor The Elective Percutaneous

More information

Coding Updates for 2013: Cardiology

Coding Updates for 2013: Cardiology Coding Updates for 2013: Cardiology Presented by: David Dunn, MD, FACS CIRCC, CPC-H, CCVTC, CCC, CCS, RCC National Coding Standards Sources of information Centers for Medicare and Medicare (CMS) Provider

More information

Perioperative Cardiac Evaluation

Perioperative Cardiac Evaluation Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project

More information

PCI vs. CABG for Left Main Disease

PCI vs. CABG for Left Main Disease The EXCEL Ti Trial Design, Status, t and Timelines Gregg W. Stone, MD Columbia University Medical Center NewYork-Presbyterian Hospital Cardiovascular Research Foundation PCI vs. CABG for Left Main Disease

More information

Repeat Coronary Revascularization Procedures after Successful Bare-Metal or Drug-Eluting Stent Implantation

Repeat Coronary Revascularization Procedures after Successful Bare-Metal or Drug-Eluting Stent Implantation Original Contribution Repeat Coronary Revascularization Procedures after Successful Bare-Metal or Drug-Eluting Stent Implantation Cynthia A. Yock, MS, J. Michael Isbill, MS, Spencer B. King III, MD, Mark

More information

06 Validation of risk prediction model

06 Validation of risk prediction model HA Territory-wide PCI Audit 2003-06 06 Validation of risk prediction model PCI Audit Working Group Central Committee (Cardiac Services) HA Convention 2007 Background Participants: All HA hospitals via

More information

Polymer-Based, Paclitaxel-Eluting TAXUS Liberté Stent in De Novo Lesions: The Pivotal TAXUS ATLAS Trial

Polymer-Based, Paclitaxel-Eluting TAXUS Liberté Stent in De Novo Lesions: The Pivotal TAXUS ATLAS Trial Polymer-Based, Paclitaxel-Eluting Stent in De Novo Lesions: The Pivotal TAXUS ATLAS Trial Mark A. Turco, John A. Ormiston, Jeffrey J. Popma, Lazar Mandinov, Charles D. O'Shaughnessy, Tift Mann, Thomas

More information

Early healing after treatment of coronary lesions by everolimus, or biolimus eluting bioresorbable polymer stents

Early healing after treatment of coronary lesions by everolimus, or biolimus eluting bioresorbable polymer stents Early healing after treatment of coronary lesions by everolimus, or biolimus eluting bioresorbable polymer stents One-month results of the study Ida Riise Balleby 1, Trine Krejberg Ørhøj 1, Christian Juhl

More information

Why the provisional single-stent approach is not always the right strategy; arguments for the development of dedicated bifurcation devices

Why the provisional single-stent approach is not always the right strategy; arguments for the development of dedicated bifurcation devices EDITORIAL n Why the provisional single-stent approach is not always the right strategy; arguments for the development of dedicated bifurcation devices Maik J. Grundeken 1, MD; Pieter R. Stella², MD, PhD;

More information

TECHNOLOGICAL INNOVATION FOR CORONARY STENTS Francesco Migliavacca

TECHNOLOGICAL INNOVATION FOR CORONARY STENTS Francesco Migliavacca LABORATORY OF BIOLOGICAL STRUCTURE MECHANICS www.labsmech.polimi.it TECHNOLOGICAL INNOVATION FOR CORONARY STENTS Francesco Migliavacca Erice, 1 maggio 2015 International School of Cardiac Surgery Introduction

More information

ORIGINAL ARTICLES: Morphology and Location of Restenosis Following Bare Metal Coronary Stenting

ORIGINAL ARTICLES: Morphology and Location of Restenosis Following Bare Metal Coronary Stenting Page 1 / 7 ORIGINAL ARTICLES: Morphology and Location of Restenosis Following Bare Metal Coronary Stenting - Marc J. Schweiger, MD, Ehsan Ansari, MD, Gregory R. Giugliano, MD, *James Mathew, MD, Ashequl

More information

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN HOSPITALIZATION CASE #: 2 8 8 0 H FY288BH4CN Has the participant indicated any of the following reasons for being admitted overnight for this case? 1. Suspected or confirmed problems with the heart, circulation,

More information

Is There A LIfe for DES after discontinuation of Clopidogrel

Is There A LIfe for DES after discontinuation of Clopidogrel Chicago 2014 Is There A LIfe for DES after discontinuation of Clopidogrel Six-month versus 24-month dual antiplatelet therapy after implantation of drug eluting stents in patients non-resistant to aspirin:

More information

STONY BROOK UNIVERSITY HOSPITAL VASCULAR CENTER CREDENTIALING POLICY

STONY BROOK UNIVERSITY HOSPITAL VASCULAR CENTER CREDENTIALING POLICY STONY BROOK UNIVERSITY HOSPITAL VASCULAR CENTER CREDENTIALING POLICY Per Medical Board decision March 18, 2008: These credentialing standards do NOT apply to peripheral angiography performed in the context

More information

Clinical Results of Unprotected Left Main Coronary Stenting

Clinical Results of Unprotected Left Main Coronary Stenting Original Articles IMAJ VOL 11 MARCH 2009 Clinical Results of Unprotected Left Main Coronary Stenting Itsik Ben-Dor MD, Hana Vaknin-Assa MD, Eli Lev MD, David Brosh MD, Shmuel Fuchs MD, Abid Assali MD and

More information

Non-invasive functional testing in 2014

Non-invasive functional testing in 2014 Non-invasive functional testing in 2014 Bjarne Nørgaard Department Cardiology B Aarhus University Hospital Skejby, Disclosures: Research grants: Edwards and Siemens Non-invasive functional testing in 2014

More information

Evaluation of Predictive Models

Evaluation of Predictive Models Evaluation of Predictive Models Assessing calibration and discrimination Examples Decision Systems Group, Brigham and Women s Hospital Harvard Medical School Harvard-MIT Division of Health Sciences and

More information

Databases in Clinical Research. Harvard-MIT Division of Health Sciences and Technology HST.951J: Medical Decision Support

Databases in Clinical Research. Harvard-MIT Division of Health Sciences and Technology HST.951J: Medical Decision Support Databases in Clinical Research Harvard-MIT Division of Health Sciences and Technology HST.951J: Medical Decision Support Overview Background: History and utility of clinical data repositories Strategies:

More information

JUL 2 2008. Ms. Kendra Basler Regulatory Affairs Associate Abbott Vascular Cardiac Therapies 3200 Lakeside Drive Santa Clara, CA 95054-2807

JUL 2 2008. Ms. Kendra Basler Regulatory Affairs Associate Abbott Vascular Cardiac Therapies 3200 Lakeside Drive Santa Clara, CA 95054-2807 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service JUL 2 2008 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Ms. Kendra Basler Regulatory Affairs Associate Abbott Vascular

More information

An Informative Guide for Heart Catheterization Patients & Families

An Informative Guide for Heart Catheterization Patients & Families An Informative Guide for Heart Catheterization Patients & Families What is a Cardiac Cath? Cardiac catheterization is a procedure used to diagnose and treat patients who have various forms of heart disease.

More information

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

Perspectives on the Selection and Duration of Dual Antiplatelet Therapy

Perspectives on the Selection and Duration of Dual Antiplatelet Therapy Perspectives on the Selection and Duration of Dual Antiplatelet Therapy Dominick J. Angiolillo, MD, PhD, FACC, FESC, FSCAI Director of Cardiovascular Research Associate Professor of Medicine University

More information

Protocol. Cardiac Rehabilitation in the Outpatient Setting

Protocol. Cardiac Rehabilitation in the Outpatient Setting Protocol Cardiac Rehabilitation in the Outpatient Setting (80308) Medical Benefit Effective Date: 07/01/14 Next Review Date: 09/15 Preauthorization No Review Dates: 07/07, 07/08, 05/09, 05/10, 05/11, 05/12,

More information

OPINION OPtical frequency domain imaging vs. INtravascular ultrasound in percutaneous coronary InterventiON

OPINION OPtical frequency domain imaging vs. INtravascular ultrasound in percutaneous coronary InterventiON OPINION OPtical frequency domain imaging vs. INtravascular ultrasound in percutaneous coronary InterventiON - Baseline preliminary results - Takashi Akasaka, MD, PhD, FESC Wakayama Medical University,

More information

Review of Intracoronary Radiation for In-Stent Restenosis

Review of Intracoronary Radiation for In-Stent Restenosis Review of Intracoronary Radiation for In-Stent Restenosis Robert Lew, MBBS, FRACP, Andrew Ajani, MD, Ron Waksman, MD, FACC Vascular Brachytherapy using beta and gamma radiation is the standard care for

More information

Antiplatelet and Antithrombotics From clinical trials to guidelines

Antiplatelet and Antithrombotics From clinical trials to guidelines Antiplatelet and Antithrombotics From clinical trials to guidelines Ashraf Reda, MD, FESC Prof and head of Cardiology Dep. Menofiya University Preisedent of EGYBAC Chairman of WGLVR One of the big stories

More information

Antiaggreganti. STEMI : cosa c è di nuovo? Heartline 2015. Genova 13 14 Novembre 2015

Antiaggreganti. STEMI : cosa c è di nuovo? Heartline 2015. Genova 13 14 Novembre 2015 Heartline 2015 Genova 13 14 Novembre 2015 STEMI : cosa c è di nuovo? Antiaggreganti Luigi Oltrona Visconti Divisione di Cardiologia IRCCS Fondazione Policlinico S. Matteo Pavia STEMI : cosa c è di nuovo?

More information

Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy

Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy File name: Cardiac Rehabilitation (Outpatient Phase II) File code: UM.REHAB.04 Origination: 08/1994 Last Review: 08/2011 Next Review:

More information

Antonio Colombo MD on behalf of the SECURITY Investigators

Antonio Colombo MD on behalf of the SECURITY Investigators Second Generation Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy - The SECURITY Randomized Clinical Trial Antonio Colombo MD on behalf of the SECURITY

More information

Q1: Global risk assessment using PROCAM, SCORE, FRAMINGHAM or REYNOLDS ecc is sufficient YES NO NEED MORE DATA DISCUSS within Taskforce Your Comments

Q1: Global risk assessment using PROCAM, SCORE, FRAMINGHAM or REYNOLDS ecc is sufficient YES NO NEED MORE DATA DISCUSS within Taskforce Your Comments Site ID: Q1: Global risk assessment using PROCAM, SCORE, FRAMINGHAM or REYLDS ecc is sufficient Q2: The value of an emerging test is best assessed using C - statistics Q3: Atherosclerosis imaging may be

More information

Diagnostic and Therapeutic Procedures

Diagnostic and Therapeutic Procedures Diagnostic and Therapeutic Procedures Diagnostic and therapeutic cardiovascular s are central to the evaluation and management of patients with cardiovascular disease. Consistent with the other sections,

More information

Feeding in Infants with Complex Congenital Heart Disease. Rachel Torok, MD Southeastern Pediatric Cardiology Society Conference September 6, 2014

Feeding in Infants with Complex Congenital Heart Disease. Rachel Torok, MD Southeastern Pediatric Cardiology Society Conference September 6, 2014 Feeding in Infants with Complex Congenital Heart Disease Rachel Torok, MD Southeastern Pediatric Cardiology Society Conference September 6, 2014 Objectives Discuss common feeding issues in patients with

More information

Subclavian Steal Syndrome By Marta Thorup

Subclavian Steal Syndrome By Marta Thorup Subclavian Steal Syndrome By Marta Thorup Definition Subclavian steal syndrome (SSS), is a constellation of signs and symptoms that arise from retrograde flow of blood in the vertebral artery, due to proximal

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

Evolu'on of Balloon Angioplasty From POBA to newer technologies NCVH May 26, 2015

Evolu'on of Balloon Angioplasty From POBA to newer technologies NCVH May 26, 2015 Evolu'on of Balloon Angioplasty From POBA to newer technologies NCVH May 26, 2015 Cezar Staniloae, MD Heart and Vascular Ins7tute New York University Medical Center Overview 1. Physics of balloon angioplasty

More information

LEADERS: 5-Year Follow-up

LEADERS: 5-Year Follow-up LEADERS: -Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable Polymer : Final Report of the LEADERS

More information

prodigy study: duration of dual antiplatelet therapy under review In BrIef In Brief NPS RADAR AuguSt 2012

prodigy study: duration of dual antiplatelet therapy under review In BrIef In Brief NPS RADAR AuguSt 2012 3 In BrIef A digest of news items about NPS RADAR, new drugs and changes to PBS listings prodigy study: duration of dual antiplatelet therapy under review Dual antiplatelet therapy with aspirin and clopidogrel

More information

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Marian Taylor, M.D. Medical University of South Carolina Director, Cardiac Rehabilitation I have no disclosures.

More information